Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
09/2005
09/14/2005EP1572131A2 Antibody therapy
09/14/2005EP1572125A2 Compositions and methods for treating tumors bearing hmfg and cea antigens
09/14/2005EP1572121A2 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
09/14/2005EP1572116A2 Compositions and methods for the treatment of immune related diseases
09/14/2005EP1572106A2 Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis
09/14/2005EP1572104A2 Induction of apoptosis by hiv-1 infected monocytic cells
09/14/2005EP1572103A2 Anti-angiogenic uses of il-6 antagonists
09/14/2005EP1572101A2 Disease treatment via antimicrobial peptide inhibitors
09/14/2005EP1572100A2 Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors
09/14/2005EP1572094A2 Sodium channel alpha subunit variants
09/14/2005EP1572091A2 Compositions and methods for the diagnosis and treatment of tumor
09/14/2005EP1572087A2 Antibodies against cancer antigen tmeff2 and uses thereof
09/14/2005EP1572082A2 Cancer-linked gene as target for chemotherapy
09/14/2005EP1572079A2 Mammalian cdr mimetibodies, compositions, methods and uses
09/14/2005EP1572077A2 Uses of monoclonal antibody 8h9
09/14/2005EP1572066A2 Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within mmp-2
09/14/2005EP1572065A2 Method and pharmaceutical composition for the treatment of multiple sclerosis
09/14/2005EP1571970A2 Diagnosis and monitoring of diseases
09/14/2005EP1571968A2 Compositions and methods for the diagnosis and treatment of tumor
09/14/2005EP1381685B1 Genes and proteins for the biosynthesis of polyketides
09/14/2005EP1328656A4 Method of predicting the clinical response to chemotherapeutic treatment with alkylating agents
09/14/2005EP1092028B1 Specific binding proteins including antibodies which bind to the necrotic centre of tumours, and uses thereof
09/14/2005EP1082141B1 Cd40 binding antibodies and ctl peptides for treating tumors
09/14/2005CN1668762A Sgk and Nedd used as diagnostic and therapeutic targets
09/14/2005CN1668754A Carotene synthase gene and uses therefor
09/14/2005CN1668721A Immunoadhesin comprising a glycoprotein VI domain
09/14/2005CN1668644A Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer
09/14/2005CN1668637A Molecular antigen arrays using a virus like particle derived from the AP205 coat protein
09/14/2005CN1668636A Recombinant production of mixtures of antibodies
09/14/2005CN1668634A Detection of secreted polypeptides
09/14/2005CN1668630A Novel isoforms of vascular endothelial cell growth inhibitor
09/14/2005CN1668335A Drug pre-targeting by means of bi-specific antibodies and hapten constructs comprising a carrier peptide and the active agent(s)
09/14/2005CN1668312A Treatment and prevention of abnormal scar formation in keloids and other cutaneous or internal wounds or lesions
09/14/2005CN1666996A Fusion protein, gene encoding same, and expression method and use thereof
09/14/2005CN1219057C Cell factor CKLF-HIA with functions of hematopoietic stimulation and immunoregulation and its variant CKLF-HIB
09/14/2005CN1218962C Somatostatin yolk antibody and its preparing process
09/14/2005CN1218961C Osteoclast formation inhibitive factor, its nucleotide sequence and preparation method
09/13/2005US6943241 Full-length cDNA
09/13/2005US6943240 Nucleic acids for high throughput screening of CpG-based immuno-agonist/antagonist
09/13/2005US6943236 Compositions and methods for the therapy and diagnosis of prostate cancer
09/13/2005US6943150 Antiapoptosis polypeptides or fusion proteins coded by nucleic acids
09/13/2005US6943020 Death domain containing receptor-4 antibodies
09/13/2005US6943014 Invention provides cDNAs encoding deoxyribonuclease II beta and isolated, purified deoxyribonuclease II beta proteins and antibodies against this protein and antisense agents targeted to cDNA or mRNA encoding deoxyribonuclease II beta
09/13/2005US6943013 DNA expression vector; host cell transformed, transfected or infected with the vector; transgenic cell, tissue or organism; HCDS1 protein
09/13/2005US6943011 Treating a cancer; obtain polypeptide coded by tumor gene, administer to human, monitor human for reduction in tumors
09/13/2005US6942992 Nucleic acid sequences encoding human slit-, megf-, and roundabout-like polypeptides
09/13/2005US6942983 An isolated monoclonal antibody is used for binding and detecting a polypeptide having amino acid sequence with valine at residue 835, modulate kinase activity in cells, protein kinase C
09/13/2005US6942982 FEBP1 protein vector host cells and method for making FEBP1 protein
09/13/2005US6942979 Method for screening substances capable of modulating the activity of a TRAAK potassium channel
09/13/2005US6942977 Immunoassays for determining vitamin b12, and reagents and kits therefor
09/13/2005US6942863 Polypeptide for use the prevention of infections associated with tissue grafting
09/13/2005US6942861 Functional bacterial protein, intimin, and its use as an antigen for protecting against infection by or transmission of bacteria expressing intimin-like proteins, such as certain pathogenic strains of Escherichial coli
09/13/2005US6942854 Orally-administered interferon-tau compositions and methods
09/13/2005CA2175476C Opioid receptor: compositions and methods
09/09/2005WO2005083444A1 Protein phosphorylation in t-cell receptor signaling pathways
09/09/2005WO2005083439A1 Protein phosphorylation in anaplastic large cell lymphoma
09/09/2005WO2005083431A2 Binding agents
09/09/2005WO2005083126A2 Alterations of fibulin genes in macular degeneration
09/09/2005WO2005083113A1 Protein phosphorylation in c-src signaling pathways
09/09/2005WO2005083088A1 E.coli o157:h7 c1 esterase inhibitor-binding protein stce and uses thereof
09/09/2005WO2005083081A1 Improved nuclease inhibitor cocktail
09/09/2005WO2005083075A1 Novel gene participating in epidermal differentiation and use thereof
09/09/2005WO2005083074A1 Tumor antigen peptides
09/09/2005WO2005083064A1 Cancerous disease modifying antibodies
09/09/2005WO2005083063A1 Cancerous disease modifying antibodies
09/09/2005WO2005082940A1 Anti-nc1 monoclonal antibody
09/09/2005WO2005082939A2 Anti-abeta antibody
09/09/2005WO2005082938A2 Anti-human tenascin monoclonal antibody
09/09/2005WO2005082937A2 A method of providing a purified, virus safe antibody preparation
09/09/2005WO2005082933A1 Novel chimeric protein, gene encoding the same, and means of judging leukemia using the gene and the protein
09/09/2005WO2005082926A1 Antibody purification
09/09/2005WO2005082483A1 A process for the purification of antibodies
09/09/2005WO2005082411A1 Method of treating abnormal cell growth using c-met and-tor inhibitors
09/09/2005WO2005082410A1 Method for inhibiting the transendothelial migration of cells such as leukocytes or tumor cells by a cd-binding substance and uses thereof
09/09/2005WO2005082409A1 Target for b-cell disorders
09/09/2005WO2005082070A2 Compositions and methods for the systemic treatment of arthritis
09/09/2005WO2005081980A2 Methods and compositions relating to chitinases and chitinase-like molecules and modulation of osteoclasts
09/09/2005WO2005081873A2 Il-13 mutein proteins, antibodies, compositions, methods and uses
09/09/2005WO2005081783A2 Method for determination and quantification of radiation or genotoxin exposure
09/09/2005WO2005081711A2 Monomethylvaline compounds capable of conjugation to ligands
09/09/2005WO2005060997A3 Medicament comprising inhibitors of long pentraxin ptx3
09/09/2005WO2005058957A3 Ztnf 12, a tumor necrosis factor
09/09/2005WO2005056606A3 Optimized antibodies that target the epidermal growth factor receptor
09/09/2005WO2005051994A3 Ztnf11, a tumor necrosis factor
09/09/2005WO2005044996A3 Chimeric receptors with 4-1bb stimulatory signaling domain
09/09/2005WO2005042714A3 Infectivity-enhanced conditionally-replicative adenovirus and uses thereof
09/09/2005WO2005035721A3 Native immunoglobulin binding reagents and methods for making and using same
09/09/2005WO2005034733A3 Methods and compositions for diagnosis and treatment of b cell chronic lymphocytic leukemia
09/09/2005WO2005028511A3 Anti-amyloid antibodies, compositions, methods and uses
09/09/2005WO2005012358A3 Use of adcc-optimized antibodies for treating weak patients
09/09/2005WO2005012330A3 AMYLOID β-PEPTIDE AND METHODS OF USE
09/09/2005WO2005007804A3 Anthrax conjugate vaccine and antibodies
09/09/2005WO2005000898A3 Use of hydrophobic-interaction-chromatography or hinge-region modifications for the production of homogeneous antibody-solutions
09/09/2005WO2004108889A3 Hybrid antibodies
09/09/2005WO2004099374A3 Methods for recombinant immunoglobulin treatment
09/09/2005WO2003084477A3 Mammalian cdr mimetibodies, compositions, methods and uses
09/09/2005WO2003057854A3 Novel proteins and nucleic acids encoding same
09/09/2005CA2841741A1 Monomethylvaline compounds capable of conjugation to ligands
09/09/2005CA2558718A1 Anti-human tenascin monoclonal antibody
09/09/2005CA2557597A1 A novel cofactor that modulates steroid receptor activities
1 ... 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 ... 1494